39,63 €
0,36 %heute
L&S, 28. März, 20:29 Uhr
ISIN
US0718131099
Symbol
BAX
Berichte

Baxter International Aktie News

Neutral
Business Wire
ein Tag alt
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2024 Annual Meeting) in a virtual format on Tuesday, May 7, 2024 at 9 a.m., Central Time, as disclosed in Baxter's proxy statement for the 2024 Annual Meeting. Online access to the 2024 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholde...
Neutral
Business Wire
28 Tage alt
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 45th Annual Institutional Investors Conference on Monday, March 4, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 4:00 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be availabl...
Positiv
Seeking Alpha
etwa ein Monat alt
Baxter International Inc. is a buy according to the analysis of price action, momentum, volume, and relative strength.
Neutral
GlobeNewsWire
etwa ein Monat alt
Baxter to act as exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA Baxter to act as exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA
Positiv
Seeking Alpha
etwa ein Monat alt
Baxter International gets its buy rating from December reaffirmed, agreeing with today's bullish consensus from SA analysts and Wall Street. Positive drivers of the bull call include recent Q4 performance, declining debt, innovative new products in the pipeline, and dividend growth. Some weak spots are an unremarkable dividend yield or future revenue growth vs peers, as well as the nature of le...
Neutral
Forbes
etwa ein Monat alt
On February 8, 2024, Baxter International BAX Inc. (NYSE: BAX, $39.64, Market Capitalization: $20.1 billion), a global medtech leader, reported steady 4Q23 results, with a mild beat vs consensus on revenues and adjusted EPS. In 4Q23, consolidated revenue increased by 3.7% YoY to $3.9 billion (up 3% on a constant currency basis).
Neutral
GlobeNewsWire
etwa ein Monat alt
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a major milestone by reaching its Interim Enrollment target of patient 90 in its TIGRIS trial.
Neutral
Business Wire
etwa ein Monat alt
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 1, 2024, to stockholders of record as of March 1, 2024. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every da...
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen